← Back to headlines
FDA Considers Authorization of Experimental Peptides
The FDA is currently evaluating whether six experimental peptides should be made available through compounding pharmacies, with a decision pending on their authorization.
10 Aug, 08:30 — 10 Aug, 08:30
